Cambridge Investment Research Advisors, Inc. Galmed Pharmaceuticals Ltd. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $27.1 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$0.29 - $84.61 $1,918 - $559,695
-6,615 Reduced 18.84%
28,500 $14,000
Q3 2022

Oct 17, 2022
BUY
$0.35 - $59.37 $2,800 - $474,960
8,000 Added 29.5%
35,115 $0
Q2 2022

Jul 13, 2022
BUY
$0.44 - $1.77 $440 - $1,770
1,000 Added 3.83%
27,115 $17,000
Q1 2022

May 12, 2022
BUY
$1.23 - $2.07 $32,121 - $54,058
26,115 New
26,115 $41,000

About Galmed Pharmaceuticals Ltd.

GLMD Quotes by TradingView
  • Ticker GLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,088,400
  • Market Cap $153M
  • Description
  • Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...
More about GLMD
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email